ATE154758T1 - Levobupivacain nützlich zur behandlung von chronischen schmerzen - Google Patents

Levobupivacain nützlich zur behandlung von chronischen schmerzen

Info

Publication number: ATE154758T1
Authority: AT; Austria
Prior art keywords: pct; chronic pain; levobupivacain; useful; treating chronic
Prior art date: 1993-10-13

Application number

AT94929595T

Other languages

English (en)

Inventor

Hazel Judith Bardsley

Laurence Mather

Original Assignee

Chiroscience Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-13

Filing date

1994-10-13

Publication date

1997-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10743430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE154758(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-10-13 Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd

1997-07-15 Application granted granted Critical

1997-07-15 Publication of ATE154758T1 publication Critical patent/ATE154758T1/de

Links

208000002193 Pain Diseases 0.000 title abstract 3
208000000094 Chronic Pain Diseases 0.000 title abstract 2
LEBVLXFERQHONN-INIZCTEOSA-N levobupivacaine Chemical compound CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-INIZCTEOSA-N 0.000 abstract 2
229960004288 levobupivacaine Drugs 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
230000000747 cardiac effect Effects 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
230000001010 compromised effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Steroid Compounds (AREA)

AT94929595T 1993-10-13 1994-10-13 Levobupivacain nützlich zur behandlung von chronischen schmerzen ATE154758T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939321061A GB9321061D0 (en)	1993-10-13	1993-10-13	Analgestic agent and its use

Publications (1)

Publication Number	Publication Date
ATE154758T1 true ATE154758T1 (de)	1997-07-15

Family

ID=10743430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94929595T ATE154758T1 (de)	1993-10-13	1994-10-13	Levobupivacain nützlich zur behandlung von chronischen schmerzen

Country Status (16)

Country	Link
US (1)	US5955479A (de)
EP (1)	EP0723444B1 (de)
JP (1)	JPH09503777A (de)
KR (1)	KR100343314B1 (de)
CN (1)	CN1074919C (de)
AT (1)	ATE154758T1 (de)
AU (1)	AU692477B2 (de)
CA (1)	CA2173208C (de)
DE (1)	DE69403969T2 (de)
DK (1)	DK0723444T3 (de)
ES (1)	ES2105766T3 (de)
GB (1)	GB9321061D0 (de)
GR (1)	GR3024787T3 (de)
HK (1)	HK1006421A1 (de)
NO (1)	NO309304B1 (de)
WO (1)	WO1995010276A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU704806B2 (en) *	1995-04-13	1999-05-06	Darwin Discovery Limited	Levobupivacaine and its use as an anaesthetic in pregnant women
GB9704370D0 (en) *	1997-03-03	1997-04-23	Chiroscience Ltd	Levobupivacaine and its use
GB9704349D0 (en) *	1997-03-03	1997-04-23	Chiroscience Ltd	Levobupivacaine and its use
GB9704352D0 (en) *	1997-03-03	1997-04-23	Chiroscience Ltd	Levobupivacaine and its use
AU8574398A (en) *	1997-07-21	1999-02-10	Astra Aktiebolag	Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en)	1997-07-21	2010-09-21	Levin Bruce H	Method for directed intranasal administration of a composition
US6432986B2 (en)	1997-07-21	2002-08-13	Bruce H. Levin	Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
WO1999004772A2 (en) *	1997-07-22	1999-02-04	Darwin Discovery Limited	Use of levobupivacaine
CA2304096C (en)	1997-09-18	2003-09-09	Pacira Pharmaceuticals, Inc.	Sustained-release liposomal anesthetic compositions
AU752802C (en)	1997-11-14	2006-04-13	Pacira Pharmaceuticals, Inc.	Production of multivesicular liposomes
KR100695588B1 (ko) *	1997-11-19	2007-03-14	다윈 디스커버리 리미티드	마취용 제형물
IL140899A0 (en)	1998-07-17	2002-02-10	Skyepharma Inc	Lipid/polymer containing pharmaceutical compositions and processes for the preparation thereof
BR0002246A (pt)	2000-04-06	2003-04-15	Cristalia Prod Quimicos Farm	Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
AU2002322024B2 (en) *	2001-05-31	2008-05-08	Pacira Pharmaceuticals, Inc.	Encapsulation of nanosuspensions in liposomes and microspheres
EP1446101B1 (de)	2001-11-14	2011-03-23	Durect Corporation	Katheterinjizierbare depotzusammensetzungen und deren verwendung
US20040001889A1 (en)	2002-06-25	2004-01-01	Guohua Chen	Short duration depot formulations
CN1684663A (zh)	2002-07-31	2005-10-19	阿尔萨公司	可注射的多模式聚合物储库组合物以及其用途
AU2002359397B2 (en)	2002-07-31	2009-01-29	Durect Corporation	Injectable depot compositions and uses thereof
US8337883B2 (en)	2006-11-03	2012-12-25	Durect Corporation	Transdermal delivery systems
DE102008037682A1 (de) *	2008-08-14	2010-04-08	Strackharn, Klaus, Dr.med.	Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
EP3079668A1 (de)	2013-12-09	2016-10-19	Durect Corporation	Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
EP3558279A4 (de) *	2016-12-26	2020-12-02	Cellix Bio Private Limited	Zusammensetzungen und verfahren zur behandlung chronischer schmerzen
US11357727B1 (en)	2021-01-22	2022-06-14	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en)	2021-01-22	2022-03-22	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en)	2021-01-22	2024-11-26	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en)	2021-01-22	2021-06-15	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
EP4415713A4 (de)	2021-10-14	2025-08-06	Pacira Pharmaceuticals Inc	Bupivacain-multivesikuläre liposomformulierungen und verwendungen davon
US12070454B1 (en)	2022-05-05	2024-08-27	Pfof Llc	Anesthetic nerve block and method
CN119677554A (zh)	2022-05-05	2025-03-21	普络夫有限责任公司	麻醉神经阻滞和方法
US12251472B1 (en)	2024-05-20	2025-03-18	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en)	2024-05-20	2024-12-03	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en)	2024-05-20	2025-04-22	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4695576A (en) *	1984-07-09	1987-09-22	Astra Lake Medel Aktiebolag	L-N-n-propylpipecolic acid-2,6-xylidide
EP0727210B1 (de) *	1993-10-13	2001-12-19	Darwin Discovery Limited	Analgetisches Mittel und dessen Verwendung
ITTO20010597A1 (it) *	2001-06-20	2002-12-20	Plaset Spa	Pompa per liquidi, in particolare pompa centrifuga per apparecchi elettrodomestici.

1993
- 1993-10-13 GB GB939321061A patent/GB9321061D0/en active Pending
1994
- 1994-10-13 WO PCT/GB1994/002248 patent/WO1995010276A1/en not_active Ceased
- 1994-10-13 DE DE69403969T patent/DE69403969T2/de not_active Expired - Lifetime
- 1994-10-13 AT AT94929595T patent/ATE154758T1/de active
- 1994-10-13 HK HK98105742A patent/HK1006421A1/en not_active IP Right Cessation
- 1994-10-13 KR KR1019960701863A patent/KR100343314B1/ko not_active Expired - Lifetime
- 1994-10-13 CA CA002173208A patent/CA2173208C/en not_active Expired - Lifetime
- 1994-10-13 US US08/628,689 patent/US5955479A/en not_active Expired - Lifetime
- 1994-10-13 ES ES94929595T patent/ES2105766T3/es not_active Expired - Lifetime
- 1994-10-13 EP EP94929595A patent/EP0723444B1/de not_active Expired - Lifetime
- 1994-10-13 JP JP7511488A patent/JPH09503777A/ja active Pending
- 1994-10-13 DK DK94929595.0T patent/DK0723444T3/da active
- 1994-10-13 CN CN94193775A patent/CN1074919C/zh not_active Expired - Lifetime
- 1994-10-13 AU AU78593/94A patent/AU692477B2/en not_active Expired
1996
- 1996-04-12 NO NO961478A patent/NO309304B1/no not_active IP Right Cessation
1997
- 1997-09-17 GR GR970402411T patent/GR3024787T3/el unknown

Also Published As

Publication number	Publication date
JPH09503777A (ja)	1997-04-15
AU692477B2 (en)	1998-06-11
GR3024787T3 (en)	1998-01-30
DK0723444T3 (da)	1997-12-29
EP0723444B1 (de)	1997-06-25
NO961478D0 (no)	1996-04-12
NO961478L (no)	1996-06-11
WO1995010276A1 (en)	1995-04-20
DE69403969T2 (de)	1997-11-20
ES2105766T3 (es)	1997-10-16
CN1133009A (zh)	1996-10-09
HK1006421A1 (en)	1999-02-26
US5955479A (en)	1999-09-21
CN1074919C (zh)	2001-11-21
CA2173208A1 (en)	1995-04-20
EP0723444A1 (de)	1996-07-31
KR100343314B1 (ko)	2003-02-19
CA2173208C (en)	2007-01-30
GB9321061D0 (en)	1993-12-01
AU7859394A (en)	1995-05-04
DE69403969D1 (de)	1997-07-31
NO309304B1 (no)	2001-01-15

Similar Documents

Publication	Publication Date	Title
ATE154758T1 (de)	1997-07-15	Levobupivacain nützlich zur behandlung von chronischen schmerzen
EP0792156A4 (de)	2000-03-01	Verfahren zur vorbeugung oder behandlung von vaskulären hämorragien und der alzheimerischen krankheit
ATE144420T1 (de)	1996-11-15	Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE69616376D1 (de)	2001-11-29	Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE69805973D1 (de)	2002-07-18	Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
ATE213411T1 (de)	2002-03-15	Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
DE69012261D1 (de)	1994-10-13	Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
ATE258796T1 (de)	2004-02-15	Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69526937D1 (de)	2002-07-11	Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE214272T1 (de)	2002-03-15	Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
ATE382061T1 (de)	2008-01-15	Mittel zur induktion von apoptosis und zur therapieanwendung
DE69333014D1 (de)	2003-07-10	Verwendung von 4-aminopyridin zur behandlung von schmerz und spastik folgende einer verletzung des rückenmarks
DE59902666D1 (de)	2002-10-17	Edelfosin zur behandlung von hirntumoren
DE69304843D1 (de)	1996-10-24	Methode zur Behandlung von Haarausfall
MXPA00010254A (es)	2002-08-06	Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
EP1056458A4 (de)	2001-06-20	Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen
DE69630055D1 (de)	2003-10-23	Verwendung von olanzapin oder eines salzes für die herstellung eines medikaments für die behandlung von autismus und mentaler retardation
ATE236630T1 (de)	2003-04-15	Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
DE69733321D1 (de)	2005-06-23	Olanzapine zur behandlung von drogenmissbrauch
ATE369143T1 (de)	2007-08-15	Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
DE69307702D1 (de)	1997-03-06	Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
ATE291434T1 (de)	2005-04-15	Verwendung von angiotensin zur behandlung von krebsmetastasierung
DE3585312D1 (de)	1992-03-12	Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
ATE288263T1 (de)	2005-02-15	Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)
ATE150645T1 (de)	1997-04-15	Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen

Legal Events

Date	Code	Title
1997-12-15	UEP	Publication of translation of european patent specification
1999-11-15	EEFA	Change of the company name
2000-02-15	EEIH	Change in the person of patent owner